Skip to content

   Pharma Publications

Neuropsychopharmacology
  • The double-edged sword of the double-stranded break
    Published on 2022-08-05
    3 years ago
  • Sleep disturbance in substance use disorders: the orexin (hypocretin) system as an emerging pharmacological target
    Published on 2022-08-05
    3 years ago
  • Plasticity markers in the human brain associated with rapid antidepressants
    Published on 2022-08-04
    3 years ago
  • Echoes of ancient DNA in living modern humans affect risk for neuropsychiatric disease and brain structure and function of networks subserving higher-order cognition
    Published on 2022-08-03
    3 years ago
  • The role of racial discrimination in dissociation and interoceptive dysfunction
    Published on 2022-08-03
    3 years ago
  • Unexpected circuit-level tradeoffs in human stress resilience
    Published on 2022-08-02
    3 years ago
  • Shaping long-range functional connectivity through prefrontal interneuron plasticity
    Published on 2022-08-01
    3 years ago
« Previous 1 … 108 109 110 111 112 … 143 Next »
Journal of Psychopharmacology
  • Effects of commonly prescribed drugs on cognition and mild cognitive impairment in healthy elderly people
    Published on 2019-06-26
    6 years ago
  • Prevalence of treatment-resistant psychoses in the community: A naturalistic study
    Published on 2019-06-26
    6 years ago
  • The effect of cannabidiol (CBD) on low-frequency activity and functional connectivity in the brain of adults with and without autism spectrum disorder (ASD)
    Published on 2019-06-25
    6 years ago
  • Endocannabinoid system imbalance in the postmortem prefrontal cortex of subjects with schizophrenia
    Published on 2019-06-25
    6 years ago
  • Frontal haemodynamic responses in depression and the effect of electroconvulsive therapy
    Published on 2019-06-25
    6 years ago
  • The serotonin transporter gene-linked polymorphic region (5-HTTLPR) and the sleep-promoting effects of tryptophan: A randomized placebo-controlled crossover study
    Published on 2019-06-25
    6 years ago
  • Impulsivity moderates the effects of dopamine D2 and mixed D1–D2 antagonists in individuals with gambling disorder
    Published on 2019-06-20
    6 years ago
« Previous 1 … 108 109 110 111 112 … 123 Next »
European Neuropsychopharmacology
  • P.856Evidence-based psychoeducational program in first psychotic episode patients
    Published on 2020-11-25
    5 years ago
  • P.831Trajectories of suicidal ideation after a first-episode psychosis: a growth mixture modeling approach
    Published on 2020-11-25
    5 years ago
  • P.857Cognitive reserve in child and adolescent offspring of patients diagnosed with schizophrenia or bipolar disorder
    Published on 2020-11-25
    5 years ago
  • P.832DRD1 protein and mRNA levels in peripheral blood lymphocytes: influence of SNPs of 5′-untranslated region and the schizophrenia disorder
    Published on 2020-11-25
    5 years ago
  • P.740 Mechanistic basis behind the antidepressant response of ketamine and hydroxynorketamine (HNK)
    Published on 2020-11-25
    5 years ago
  • P.834Hyperactivated brain response to fear and disgust in schizophrenia
    Published on 2020-11-25
    5 years ago
  • P.836Metabolic syndrome and long-acting injected (LAI) preparations in schizophrenia: a “real-world” study
    Published on 2020-11-25
    5 years ago
« Previous 1 … 108 109 110 111 112 … 144 Next »

   Pharma Pub